Arista Networks is engaged in providing cloud networking solutions, which consist of its Extensible Operating System (EOS), a set of network applications and its Ethernet switching and routing platforms. The programmability of EOS enable the company to create a set of software applications that address the requirements of cloud networking, including workflow automation, network visibility and analytics, and enable the company to integrate with third-party applications for virtualization, management, automation, orchestration and network services. EOS supports cloud and virtualization solutions, including VMware NSX, Microsoft System Center, OpenStack and other cloud management frameworks.

Fitbit is a technology company focused on delivering health solutions. The Fitbit platform combines wearable devices with software and services. The company's wearable devices, which include health and fitness trackers and smartwatches, enable its users to view data about their daily activity, exercise and sleep in real-time. The company's software and services, which include an online dashboard and mobile app, provide its users with data analytics, motivational and social tools, and virtual coaching through customized fitness plans and workouts. The company's platform also includes software that helps to encourage healthy behavior changes in three areas: activity, sleep, and nutrition.

Frequency Electronics is engaged in precision time and frequency generation technology. The company's segments are: FEI-NY and FEI-Zyfer. The FEI-NY segment includes the operations of the company's wholly-owned subsidiaries, FEI-Asia and FEI-Elcom. FEI-Asia functions as a manufacturing facility for FEI-NY and FEI-Zyfer. FEI-Elcom provides design and technical support for the FEI-NY segment's business. The FEI-Zyfer segment designs and manufactures products which incorporate global positioning systems technologies and clocks designed and manufactured at FEI-NY. FEI-Zyfer sells its products to both commercial and U.S. Government customers and collaborates with FEI-NY on joint product development activities.

International Flavors & Fragrances is a creator and manufacturer of taste, scent and complementary adjacent products, including cosmetic active and natural health ingredients. The company's operating segments are Taste and Scent. The Taste segment develops a range of different flavors and taste offerings for its customers, most of which are tailor-made. The company's Taste business is comprised of various portfolios across flavor compounds, savory solutions, inclusions and nutrition and specialty ingredients. The Scent segment creates fragrance compounds and fragrance ingredients for the household and personal care products. The company also produces cosmetic active and functional ingredients for use in cosmetics.

Landec designs, develops, manufactures and sells health and wellness products for food and biomaterials markets. The company operates its business in two reportable business segments: Curation Foods, and Lifecore. The Curation Foods business is comprised of Curation Foods' packaged vegetables business sold primarily under the Eat Smart? brand, O Olive Oil & Vinegar? olive oils and wine vinegars, and Yucatan? and Cabo Fresh? guacamole and avocado food products. Lifecore is involved in the manufactures of pharmaceutical-grade sodium hyaluronate in bulk form as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures.

Ligand Pharmaceuticals is a biopharmaceutical company focused on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines. The company employs research technologies such as antibody discovery technologies, structure-based drug design, formulation science and liver targeted pro-drug technologies to assist companies in their work toward securing prescription drug and biologic approvals. The company's collaboration partners and licensees have programs in clinical development targeting cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney disease, among others.

Marvell Technology Group is a semiconductor provider of application-specific products. The company is focused on the development of System-on-a-Chip devices, utilizing its technology portfolio of intellectual property in the areas of analog, mixed-signal, digital signal processing, and embedded and standalone integrated circuits. The company develops integrated hardware platforms along with software that incorporates digital computing technologies. In storage, the company is engaged in fibre channel products and data storage controller solutions spanning cloud, enterprise, edge and personal computing markets. The company's networking products include ethernet solutions, embedded processors and WiFi connectivity solutions.

Opko Health is a healthcare company. The company manages two segments: Diagnostics, which provides laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional healthcare; and Pharmaceutical, which includes Rayaldee for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease (CKD) and vitamin D insufficiency, and Alpharen (Fermagate Tablets) for the treatment of hyperphosphatemia in CKD patients requiring regular hemodialysis.

Veritone is a provider of artificial intelligence (AI) computing solutions. The company has developed aiWARE?, a proprietary AI operating system that integrates and orchestrates an open ecosystem of performing cognitive engines. The company'saiWARE platform incorporates proprietary technology to integrate and intelligently orchestrate a variety of cognitive engine capabilities to mimic human cognitive functions. The company also operates a full service media advertising agency. The company's services include media planning and strategy, advertisement buying and placement, campaign messaging, clearance verification and attribution, and custom analytics.

Vical researches and develops biopharmaceutical products, including those based on the company's patented DNA delivery technologies, for the prevention and treatment of serious or life-threatening diseases. The company has three active development programs in the area of infectious disease comprised of: HSV-2 therapeutic vaccine, VCL-HB01, to treat patients with symptomatic genital herpes infection; antifungal VL-2397 for the treatment of patients with invasive aspergillosis; and an ongoing early stage development program of a treatment for chronic hepatitis B virus infection based on its DNA and lipid-delivery technologies.

Webster Financial is a bank holding company and financial holding company. The company, through its subsidiary, Webster Bank, National Association, delivers banking, investment, and financial services. The company provides mortgage lending, financial planning, trust, and investment services through banking centers, ATMs, a customer care center, and a range of web and mobile-based banking services. The company also provides equipment financing, commercial real estate lending, asset-based lending, and treasury and payment solutions primarily in the eastern United States. The company provides health savings accounts, while also delivers health reimbursement arrangements, and commuter benefit account administration services.